Search

everythinglearnresearchcommunity

for

Search:↓

Ginsenoside F2 may help prevent hair loss and promote hair growth better than finasteride.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

FGF5 gene mutations cause unusually long eyelashes by affecting hair growth regulation.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

FGF18 treatment during hair's resting phase can protect against hair loss from radiation.

Targeting the TNFRSF1B gene may help treat hair loss.

A small change in the TRPS1 gene leads to a less severe form of a syndrome affecting hair, nose, and finger development.

EDA2R gene linked to hair loss.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

DNAJB9 cfRNA could help diagnose and treat female hair loss.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

The FGF5 gene determines hair length in dogs.

The treatment increased hair growth and thickness in patients with hair loss.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

GDNF signaling helps in hair growth and skin healing after a wound.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

CRF can cause hair loss, but blocking its receptors might prevent this.

VEGFR-2 activation is likely involved in hair follicle growth, survival, and development.

The HCR gene contributes to psoriasis risk.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Sfrp2 increases during hair follicle catagen phase and slows keratinocyte growth.

TGFβ-2 may cause hair loss in androgenetic alopecia.

KGF and its receptor are found in enlarged prostate tissue and KGF strongly increases cell growth.

2′‐Fucosyllactose reduces hair loss and promotes hair growth in mice.